Direxion Daily S&P Biotech Bull 3X ETF
LABU
33 hedge funds and large institutions have $56.7M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 12 closing their positions.
28% more capital invested
Capital invested by funds: $44.4M → $56.7M (+$12.3M)
19% more call options, than puts
Call options by funds: $185M | Put options by funds: $156M
4.68% more ownership
Funds ownership: 5.77% → 10.45% (+4.7%)
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
18% less funds holding
Funds holding: 40 → 33 (-7)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JF
Jump Financial
Chicago,
Illinois
|
+$9.13M |
| 2 |
Goldman Sachs
New York
|
+$5.2M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.26M |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$2.35M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$3.65M |
| 2 |
IMC Chicago
Chicago,
Illinois
|
-$2.15M |
| 3 |
GS
GTS Securities
New York
|
-$1.67M |
| 4 |
Morgan Stanley
New York
|
-$1.01M |
| 5 |
TSS
Two Sigma Securities
New York
|
-$905K |
LABU Hedge Fund Activity: Q1 2026 in Review
33 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2026, worth a combined $56.7M — up 28% from $44.4M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of LABU and 6 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 10 added.
The largest buyer was Jump Financial, opening a new position worth an estimated $9.13M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $3.65M sold.
- 33 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2026, down from 40 in Q4 2025.
- Funds reported $56.7M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2026, up 28% quarter-over-quarter.
- 6 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2026 and 12 closed out, a net change of -6 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2026 was Jump Financial, an estimated $9.13M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2026 was Renaissance Technologies, an estimated $3.65M sold.
Based on aggregated 13F filings for Q1 2026.